弥散加权MRI检测Fontan患者肝纤维化及其功能相关性
58.7%患者诊断为晚期肝纤维化(重度37.0%,肝硬化21.7%)。血小板计数和胆固醇水平随纤维化严重程度增加而下降。联合血小板、胆固醇、Fontan术后年数和瞬时弹性成像的复合评分预测晚期肝纤维化能力最佳(C统计量0.817±0.071,P<0.001),截断值5.0时灵敏度78%、特异度82%。
要点
- 弥散加权MRI有助于检测Fontan患者肝纤维化,且与肝功能异常相关。
- 血小板计数(ρ=-0.456,P=0.001)和胆固醇(ρ=-0.383,P=0.009)随纤维化加重而下降。
- 复合评分>5.0时考虑及时行弥散加权成像和早期管理肝并发症。
核心结论
- 在Fontan患者中,弥散加权成像有助于检测与肝功能异常相关的肝纤维化,并提出一个简单评分用于长期监测和早期发现晚期肝病。
主要发现
- 血小板计数(Spearman's ρ:-0.456,P=0.001)和胆固醇水平(Spearman's ρ:-0.383,P=0.009)随纤维化严重程度增加而下降。
- 瞬时弹性成像截断值14.2 kPa预测晚期肝纤维化存在,但阳性预测值低。
- 联合血小板计数、胆固醇、Fontan术后年数和瞬时弹性成像值的复合评分预测晚期肝纤维化能力最满意(C统计量0.817±0.071,P<0.001)。
- 复合评分截断值5.0时灵敏度78%、特异度82%。
关键数值与推荐
- 瞬时弹性成像截断值14.2 kPa用于预测晚期肝纤维化存在,但阳性预测值低。
- 复合评分截断值5.0时灵敏度78%、特异度82%。
临床怎么用
- 对于计算评分>5.0的成人Fontan患者,可考虑及时行弥散加权成像和早期管理肝并发症。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The evaluation of Fontan-associated liver disease is often challenging. Diffusion-weighted magnetic resonance imaging can detect hepatic fibrosis from capillary perfusion and diffusion abnormalities from extracellular matrix accumulation. This study investigated its role in the evaluation of liver disease in Fontan patients and explored possible diagnostic methods for early detection of advanced liver fibrosis. METHODS: Stable adult Fontan patients who could safely be examined with magnetic resonance imaging were enrolled, and blood biomarkers, transient elastography were also examined. RESULTS: Forty-six patients received diffusion-weighted imaging; and 58.7% were diagnosed with advanced liver fibrosis (severe liver fibrosis, 37.0%, and cirrhosis 21.7%). Two parameters of hepatic dysfunction, platelet counts (Spearman's ρ: -0.456, P = 0.001) and cholesterol levels (Spearman's ρ: -0.383, P = 0.009), decreased with increasing severity of fibrosis. Using transient elastography, a cut-off value of 14.2 kPa predicted the presence of advanced liver fibrosis, but with a low positive predictive value. When we included platelet count, cholesterol, post-Fontan years and transient elastography values as a composite, the capability of predicting advanced liver fibrosis was the most satisfactory (C statistic 0.817 ± 0.071, P < 0.001). A cut-off value of 5.0 revealed a sensitivity of 78% and a specificity of 82%. CONCLUSIONS: In Fontan patients, diffusion-weighted imaging was helpful in detecting liver fibrosis that was correlated with hepatic dysfunction. A simple score was proposed for long-term surveillance and early detection of advanced liver disease in adult Fontan patients. For adult Fontan patients with a calculated score > 5.0, we may consider timely diffusion-weight imaging and early management for liver complications.
引用
- Lu CW, Wu CH, Huang MT, et al. Liver fibrosis detected by diffusion-weighted magnetic resonance imaging and its functional correlates in Fontan patients. Eur J Cardiothorac Surg. 2024. PMID: 38913856. doi:10.1093/ejcts/ezae249
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。